• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[1993 - 1996年丹麦的多重耐药结核病]

[Multiresistant tuberculosis in Denmark 1993-1996].

作者信息

Viskum K, Kok-Jensen A

机构信息

Lungemedicinsk klinik, Rigshospitalet, København.

出版信息

Ugeskr Laeger. 1998 May 18;160(21):3066-9.

PMID:9621779
Abstract

Infections with multiresistant tubercle bacilli have also become a problem in the rich part of the world. The reasons are lack of compliance in patients with life style problems and ineffectiveness of the health system due to lack of fundings. During a four year period, 1993-1996 ten patients were seen in Denmark with tuberculosis due to multiresistant Mycobacterium tuberculosis. Nine were infected abroad, one developed MDR-TB during treatment in Denmark. It is possible to cure these patients, but it is expensive and takes a long time. In the future more cases created within Denmark are likely to be seen due to lack of funding for the tuberculosis programme and, depending on immigration, further cases created abroad are expected.

摘要

多重耐药结核杆菌感染在世界富裕地区也已成为一个问题。原因在于存在生活方式问题的患者依从性差,以及卫生系统因缺乏资金而效率低下。在1993年至1996年的四年期间,丹麦有10名患者因多重耐药结核分枝杆菌感染患结核病。其中9人在国外感染,1人在丹麦接受治疗期间患上耐多药结核病。治愈这些患者是有可能的,但费用高昂且耗时长久。未来,由于结核病防治项目缺乏资金,丹麦国内可能会出现更多此类病例,而且根据移民情况,预计还会有更多在国外感染的病例。

相似文献

1
[Multiresistant tuberculosis in Denmark 1993-1996].[1993 - 1996年丹麦的多重耐药结核病]
Ugeskr Laeger. 1998 May 18;160(21):3066-9.
2
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
3
[Resistant tuberculosis in Denmark].
Ugeskr Laeger. 2001 Mar 26;163(13):1842-6.
4
Drug-resistant tuberculosis.
Clin Chest Med. 1989 Sep;10(3):341-53.
5
[Pulmonary tuberculosis in elderly patients].老年患者的肺结核
Kyobu Geka. 2005 Jul;58(8 Suppl):724-8.
6
In vitro drug resistance and response to therapy in pulmonary tuberculosis patients under a DOTS programme in south India.印度南部直接观察治疗短程化疗(DOTS)项目下肺结核患者的体外耐药性及治疗反应
Trans R Soc Trop Med Hyg. 2009 Jun;103(6):564-70. doi: 10.1016/j.trstmh.2009.01.005. Epub 2009 Feb 24.
7
Pattern of mycobacterial resistance to four anti-tuberculosis drugs in pulmonary tuberculosis patients in the state of Qatar after the implementation of DOTS and a limited expatriate screening programme.在实施直接观察治疗短程化疗(DOTS)及有限的外籍人员筛查计划后,卡塔尔国肺结核患者中分枝杆菌对四种抗结核药物的耐药模式。
Int J Tuberc Lung Dis. 2001 Dec;5(12):1116-21.
8
Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.肺切除术联合基于异烟肼和利福平的药物治疗用于耐多药和广泛耐药结核病患者。
Int J Infect Dis. 2009 Mar;13(2):170-5. doi: 10.1016/j.ijid.2008.06.001. Epub 2008 Sep 2.
9
[Mycobacterium tuberculosis resistance to antitubercular agents in Antananarivo in 2000].2000年塔那那利佛结核分枝杆菌对抗结核药物的耐药性
Arch Inst Pasteur Madagascar. 2002;68(1-2):44-7.
10
Prevalence of primary and acquired resistance of Mycobacterium tuberculosis to antituberculosis drugs in Benin after 12 years of short-course chemotherapy.经过12年短程化疗后,贝宁结核分枝杆菌对抗结核药物的原发性和获得性耐药率。
Int J Tuberc Lung Dis. 1999 Jun;3(6):466-70.